|
AdvisorShares Pure US Cannabis ETF | MSOS | BNY Mellon Equity Income Fund Class Y | DQIYX | BNY Mellon Equity Income Fund Class C | DQICX | OK Dream529 Money Market Portfolio A | FOMMX | BNY Mellon Equity Income Fund Class I | DQIRX | BNY Mellon Equity Income Fund Class A | DQIAX | Nifty India Financials ETF | INDF | Morgan Creek-Exos Active SPAC Arbitrage ETF | CSH | Grizzle Growth ETF | GRZZ | FIS Knights of Columbus Global Belief ETF | KOCG |
Gross Expense Ratio*
0.81%
SEC 30 Day Yield (as of 01/31/23 )
--
Ann. Dividend/Yield
--/--
Ex-Dividend Date
12/23/2021
Fund Inception
09/01/2020
|
 Loading...
The chart is currently unavailable.
|
The investment seeks long-term capital appreciation.The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
|
Market Return % (as of 01/31/2023) |
NAV Return % (as of 01/31/2023) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Month |
-4.15% |
-4.89% |
-41.46% |
-40.36% |
3-Month |
-39.42% |
-38.58% |
-21.55% |
-20.86% |
6-Month |
-42.54% |
-42.03% |
-32.46% |
-31.59% |
Year-to-date |
-4.15% |
-4.89% |
-72.68% |
-72.26% |
1-Year |
-68.17% |
-67.97% |
-72.68% |
-72.26% |
3-Year |
-- |
-- |
-- |
-- |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-- |
-41.85% |
-- |
-41.75% |
Inception Date: September 01, 2020
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 01/31/2023) |
NAV Return % (as of 01/31/2023) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Year |
-68.17% |
-67.97% |
-72.68% |
-72.26% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-- |
-41.85% |
-- |
-41.75% |
Inception Date: September 01, 2020
No Sector Data Available.
|
No Holdings Data Available.
|
|
|